24.11.2017

LIFE SCIENCE AND HEALTH INVESTOR LUNCH at SLUSH 2017

Cerenion Oy is one of only 20 companies invited to present to a group of international investors at the Life Science and Health Investor Lunch, taking place on November 30th 2017 in Helsinki, Finland.
The event organized by Tech Tour, Health Capital Helsinki, Finpro and Tekes in collaboration with Slush will take place at Messukeskus as a side event of SLUSH 2017. The lunch will bring together highly promising preselected life science and health startups with international investors focusing on biotech, pharma, diagnostics, personalized medicine, remote monitoring and diagnosis, as well as other life science sectors.
Cerenion Oy will be represented by Dr. Timo Koskela, CEO and Co-founder, at the event. If you would like to arrange a meeting with us at the event please contact Timo directly.

Find out more

Timo Koskela
PhD (Eng.), MSc (Econ.&Bus.Adm)
CFO, Co-founder
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
OULU
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
FINLAND
HELSINKI
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
FINLAND
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy